 | • レポートコード：D0GIR-04431 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、インフルエンザ（インフルエンザ）ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。インフルエンザ（インフルエンザ）ワクチンの種類別市場規模（分割インフルエンザワクチン、パンデミックインフルエンザワクチン、サブユニットインフルエンザワクチン、4価インフルエンザワクチン）、用途別市場規模（幼児（6ヶ月〜3歳）、大人・3歳以上）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Hualan Bio、Changsheng Biological、SANOFI、CCBIO、SINOVAC、Aleph Biomedical、GSK、ZYAK、Adimmune、SIOBP、Aimei Hissen、Tianyuan Bio-pharma(Novartis)、Simcere Vaxtec ・地域別グローバル市場分析 2015年-2020年 ・インフルエンザ（インフルエンザ）ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・インフルエンザ（インフルエンザ）ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・インフルエンザ（インフルエンザ）ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・インフルエンザ（インフルエンザ）ワクチンの南米市場（ブラジル、アルゼンチン） ・インフルエンザ（インフルエンザ）ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：分割インフルエンザワクチン、パンデミックインフルエンザワクチン、サブユニットインフルエンザワクチン、4価インフルエンザワクチン ・用途別分析：幼児（6ヶ月〜3歳）、大人・3歳以上 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Flu (Influenza) Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Flu (Influenza) Vaccine sales will be xx in 2020 from Flu (Influenza) Vaccine million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Flu (Influenza) Vaccine market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Flu (Influenza) Vaccine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Flu (Influenza) Vaccine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Flu (Influenza) Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Flu (Influenza) Vaccine market has been segmented into
Split Influenza Vaccine
Pandemic Influenza Vaccine
Subunit Influenza Vaccine
Quadrivalent Influenza Vaccine
By Application, Flu (Influenza) Vaccine has been segmented into:
For Children (6 months to 3 years)
For Adults and Children over 3 years
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Flu (Influenza) Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Flu (Influenza) Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Flu (Influenza) Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Flu (Influenza) Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Flu (Influenza) Vaccine Market Share Analysis
Flu (Influenza) Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Flu (Influenza) Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Flu (Influenza) Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Flu (Influenza) Vaccine are:
Hualan Bio
Changsheng Biological
SANOFI
CCBIO
SINOVAC
Aleph Biomedical
GSK
ZYAK
Adimmune
SIOBP
Aimei Hissen
Tianyuan Bio-pharma(Novartis)
Simcere Vaxtec
Among other players domestic and global, Flu (Influenza) Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flu (Influenza) Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Flu (Influenza) Vaccine, with price, sales, revenue and global market share of Flu (Influenza) Vaccine in 2018 and 2019.
Chapter 3, the Flu (Influenza) Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flu (Influenza) Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Flu (Influenza) Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Flu (Influenza) Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Flu (Influenza) Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Flu (Influenza) Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Split Influenza Vaccine
1.2.3 Pandemic Influenza Vaccine
1.2.4 Subunit Influenza Vaccine
1.2.5 Quadrivalent Influenza Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Flu (Influenza) Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Overview of Global Flu (Influenza) Vaccine Market
1.4.1 Global Flu (Influenza) Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Flu (Influenza) Vaccine Industry Impact
1.6.1 COVID-19 Potential Implications for the Flu (Influenza) Vaccine
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Flu (Influenza) Vaccine
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Hualan Bio
2.1.1 Hualan Bio Details
2.1.2 Hualan Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Hualan Bio SWOT Analysis
2.1.4 Hualan Bio Product and Services
2.1.5 Hualan Bio Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Changsheng Biological
2.2.1 Changsheng Biological Details
2.2.2 Changsheng Biological Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Changsheng Biological SWOT Analysis
2.2.4 Changsheng Biological Product and Services
2.2.5 Changsheng Biological Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 SANOFI
2.3.1 SANOFI Details
2.3.2 SANOFI Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 SANOFI SWOT Analysis
2.3.4 SANOFI Product and Services
2.3.5 SANOFI Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CCBIO
2.4.1 CCBIO Details
2.4.2 CCBIO Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CCBIO SWOT Analysis
2.4.4 CCBIO Product and Services
2.4.5 CCBIO Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 SINOVAC
2.5.1 SINOVAC Details
2.5.2 SINOVAC Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 SINOVAC SWOT Analysis
2.5.4 SINOVAC Product and Services
2.5.5 SINOVAC Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Aleph Biomedical
2.6.1 Aleph Biomedical Details
2.6.2 Aleph Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Aleph Biomedical SWOT Analysis
2.6.4 Aleph Biomedical Product and Services
2.6.5 Aleph Biomedical Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GSK SWOT Analysis
2.7.4 GSK Product and Services
2.7.5 GSK Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 ZYAK
2.8.1 ZYAK Details
2.8.2 ZYAK Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 ZYAK SWOT Analysis
2.8.4 ZYAK Product and Services
2.8.5 ZYAK Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Adimmune
2.9.1 Adimmune Details
2.9.2 Adimmune Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Adimmune SWOT Analysis
2.9.4 Adimmune Product and Services
2.9.5 Adimmune Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 SIOBP
2.10.1 SIOBP Details
2.10.2 SIOBP Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 SIOBP SWOT Analysis
2.10.4 SIOBP Product and Services
2.10.5 SIOBP Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Aimei Hissen
2.11.1 Aimei Hissen Details
2.11.2 Aimei Hissen Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Aimei Hissen SWOT Analysis
2.11.4 Aimei Hissen Product and Services
2.11.5 Aimei Hissen Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Tianyuan Bio-pharma(Novartis)
2.12.1 Tianyuan Bio-pharma(Novartis) Details
2.12.2 Tianyuan Bio-pharma(Novartis) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Tianyuan Bio-pharma(Novartis) SWOT Analysis
2.12.4 Tianyuan Bio-pharma(Novartis) Product and Services
2.12.5 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Simcere Vaxtec
2.13.1 Simcere Vaxtec Details
2.13.2 Simcere Vaxtec Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Simcere Vaxtec SWOT Analysis
2.13.4 Simcere Vaxtec Product and Services
2.13.5 Simcere Vaxtec Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Flu (Influenza) Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Flu (Influenza) Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Flu (Influenza) Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Flu (Influenza) Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Flu (Influenza) Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Flu (Influenza) Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Flu (Influenza) Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Flu (Influenza) Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Flu (Influenza) Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.4 France Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Flu (Influenza) Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Flu (Influenza) Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Flu (Influenza) Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.5 India Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Flu (Influenza) Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Flu (Influenza) Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Flu (Influenza) Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Flu (Influenza) Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Flu (Influenza) Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Flu (Influenza) Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Flu (Influenza) Vaccine Price by Type (2015-2020)
11 Global Flu (Influenza) Vaccine Market Segment by Application
11.1 Global Flu (Influenza) Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Flu (Influenza) Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Flu (Influenza) Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Flu (Influenza) Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Flu (Influenza) Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Flu (Influenza) Vaccine Market Forecast (2021-2025)
12.2.2 Europe Flu (Influenza) Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Flu (Influenza) Vaccine Market Forecast (2021-2025)
12.2.4 South America Flu (Influenza) Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Flu (Influenza) Vaccine Market Forecast (2021-2025)
12.3 Flu (Influenza) Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Flu (Influenza) Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Flu (Influenza) Vaccine Market Share Forecast by Type (2021-2025)
12.4 Flu (Influenza) Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Flu (Influenza) Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Flu (Influenza) Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Flu (Influenza) Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Flu (Influenza) Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Flu (Influenza) Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Flu (Influenza) Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 9. Hualan Bio Flu (Influenza) Vaccine Major Business
Table 10. Hualan Bio Flu (Influenza) Vaccine Total Revenue (USD Million) (2018-2019)
Table 11. Hualan Bio SWOT Analysis
Table 12. Hualan Bio Flu (Influenza) Vaccine Product and Services
Table 13. Hualan Bio Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Changsheng Biological Basic Information, Manufacturing Base and Competitors
Table 15. Changsheng Biological Flu (Influenza) Vaccine Major Business
Table 16. Changsheng Biological Flu (Influenza) Vaccine Total Revenue (USD Million) (2018-2019)
Table 17. Changsheng Biological SWOT Analysis
Table 18. Changsheng Biological Flu (Influenza) Vaccine Product and Services
Table 19. Changsheng Biological Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. SANOFI Basic Information, Manufacturing Base and Competitors
Table 21. SANOFI Flu (Influenza) Vaccine Major Business
Table 22. SANOFI Flu (Influenza) Vaccine Total Revenue (USD Million) (2018-2019)
Table 23. SANOFI SWOT Analysis
Table 24. SANOFI Flu (Influenza) Vaccine Product and Services
Table 25. SANOFI Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. CCBIO Basic Information, Manufacturing Base and Competitors
Table 27. CCBIO Flu (Influenza) Vaccine Major Business
Table 28. CCBIO Flu (Influenza) Vaccine Total Revenue (USD Million) (2018-2019)
Table 29. CCBIO SWOT Analysis
Table 30. CCBIO Flu (Influenza) Vaccine Product and Services
Table 31. CCBIO Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. SINOVAC Basic Information, Manufacturing Base and Competitors
Table 33. SINOVAC Flu (Influenza) Vaccine Major Business
Table 34. SINOVAC Flu (Influenza) Vaccine Total Revenue (USD Million) (2018-2019)
Table 35. SINOVAC SWOT Analysis
Table 36. SINOVAC Flu (Influenza) Vaccine Product and Services
Table 37. SINOVAC Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Aleph Biomedical Basic Information, Manufacturing Base and Competitors
Table 39. Aleph Biomedical Flu (Influenza) Vaccine Major Business
Table 40. Aleph Biomedical Flu (Influenza) Vaccine Total Revenue (USD Million) (2018-2019)
Table 41. Aleph Biomedical SWOT Analysis
Table 42. Aleph Biomedical Flu (Influenza) Vaccine Product and Services
Table 43. Aleph Biomedical Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. GSK Basic Information, Manufacturing Base and Competitors
Table 45. GSK Flu (Influenza) Vaccine Major Business
Table 46. GSK Flu (Influenza) Vaccine Total Revenue (USD Million) (2018-2019)
Table 47. GSK SWOT Analysis
Table 48. GSK Flu (Influenza) Vaccine Product and Services
Table 49. GSK Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. ZYAK Basic Information, Manufacturing Base and Competitors
Table 51. ZYAK Flu (Influenza) Vaccine Major Business
Table 52. ZYAK Flu (Influenza) Vaccine Total Revenue (USD Million) (2018-2019)
Table 53. ZYAK SWOT Analysis
Table 54. ZYAK Flu (Influenza) Vaccine Product and Services
Table 55. ZYAK Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Adimmune Basic Information, Manufacturing Base and Competitors
Table 57. Adimmune Flu (Influenza) Vaccine Major Business
Table 58. Adimmune Flu (Influenza) Vaccine Total Revenue (USD Million) (2018-2019)
Table 59. Adimmune SWOT Analysis
Table 60. Adimmune Flu (Influenza) Vaccine Product and Services
Table 61. Adimmune Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. SIOBP Basic Information, Manufacturing Base and Competitors
Table 63. SIOBP Flu (Influenza) Vaccine Major Business
Table 64. SIOBP Flu (Influenza) Vaccine Total Revenue (USD Million) (2018-2019)
Table 65. SIOBP SWOT Analysis
Table 66. SIOBP Flu (Influenza) Vaccine Product and Services
Table 67. SIOBP Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Aimei Hissen Basic Information, Manufacturing Base and Competitors
Table 69. Aimei Hissen Flu (Influenza) Vaccine Major Business
Table 70. Aimei Hissen Flu (Influenza) Vaccine Total Revenue (USD Million) (2018-2019)
Table 71. Aimei Hissen SWOT Analysis
Table 72. Aimei Hissen Flu (Influenza) Vaccine Product and Services
Table 73. Aimei Hissen Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Tianyuan Bio-pharma(Novartis) Basic Information, Manufacturing Base and Competitors
Table 75. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Major Business
Table 76. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Total Revenue (USD Million) (2018-2019)
Table 77. Tianyuan Bio-pharma(Novartis) SWOT Analysis
Table 78. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product and Services
Table 79. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Simcere Vaxtec Basic Information, Manufacturing Base and Competitors
Table 81. Simcere Vaxtec Flu (Influenza) Vaccine Major Business
Table 82. Simcere Vaxtec Flu (Influenza) Vaccine Total Revenue (USD Million) (2018-2019)
Table 83. Simcere Vaxtec SWOT Analysis
Table 84. Simcere Vaxtec Flu (Influenza) Vaccine Product and Services
Table 85. Simcere Vaxtec Flu (Influenza) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Global Flu (Influenza) Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 87. Global Flu (Influenza) Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 88. Global Flu (Influenza) Vaccine Sales by Regions (2015-2020) (K Units)
Table 89. Global Flu (Influenza) Vaccine Sales Market Share by Regions (2015-2020)
Table 90. Global Flu (Influenza) Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 91. North America Flu (Influenza) Vaccine Sales by Countries (2015-2020) (K Units)
Table 92. North America Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table 93. North America Flu (Influenza) Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 94. North America Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Table 95. Europe Flu (Influenza) Vaccine Sales by Countries (2015-2020) (K Units)
Table 96. Europe Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table 97. Europe Flu (Influenza) Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 98. Asia-Pacific Flu (Influenza) Vaccine Sales by Regions (2015-2020) (K Units)
Table 99. Asia-Pacific Flu (Influenza) Vaccine Sales Market Share by Regions (2015-2020)
Table 100. Asia-Pacific Flu (Influenza) Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 101. South America Flu (Influenza) Vaccine Sales by Countries (2015-2020) (K Units)
Table 102. South America Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table 103. South America Flu (Influenza) Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 104. South America Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Table 105. Middle East & Africa Flu (Influenza) Vaccine Sales by Countries (2015-2020) (K Units)
Table 106. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Table 107. Middle East & Africa Flu (Influenza) Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 108. Middle East & Africa Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Table 109. Global Flu (Influenza) Vaccine Sales by Type (2015-2020) (K Units)
Table 110. Global Flu (Influenza) Vaccine Sales Share by Type (2015-2020)
Table 111. Global Flu (Influenza) Vaccine Revenue by Type (2015-2020) (USD Million)
Table 112. Global Flu (Influenza) Vaccine Revenue Share by Type (2015-2020)
Table 113. Global Flu (Influenza) Vaccine Sales by Application (2015-2020) (K Units)
Table 114. Global Flu (Influenza) Vaccine Sales Share by Application (2015-2020)
Table 115. Global Flu (Influenza) Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 116. Global Flu (Influenza) Vaccine Market Share Forecast by Regions (2021-2025)
Table 117. Global Flu (Influenza) Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 118. Global Flu (Influenza) Vaccine Market Share Forecast by Type (2021-2025)
Table 119. Global Flu (Influenza) Vaccine Sales Forecast by Application (2021-2025)
Table 120. Global Flu (Influenza) Vaccine Market Share Forecast by Application (2021-2025)
Table 121. Direct Channel Pros & Cons
Table 122. Indirect Channel Pros & Cons
Table 123. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Flu (Influenza) Vaccine Picture
Figure 2. Global Sales Market Share of Flu (Influenza) Vaccine by Type in 2019
Figure 3. Split Influenza Vaccine Picture
Figure 4. Pandemic Influenza Vaccine Picture
Figure 5. Subunit Influenza Vaccine Picture
Figure 6. Quadrivalent Influenza Vaccine Picture
Figure 7. Flu (Influenza) Vaccine Sales Market Share by Application in 2018
Figure 8. For Children (6 months to 3 years) Picture
Figure 9. For Adults and Children over 3 years Picture
Figure 10. Global Flu (Influenza) Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Flu (Influenza) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Flu (Influenza) Vaccine Sales Market Share by Manufacturer in 2019
Figure 31. Global Flu (Influenza) Vaccine Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Flu (Influenza) Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Flu (Influenza) Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Flu (Influenza) Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Flu (Influenza) Vaccine Revenue Market Share by Regions (2015-2020)
Figure 38. Global Flu (Influenza) Vaccine Revenue Market Share by Regions in 2018
Figure 39. North America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Europe Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure 42. South America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Figure 44. North America Flu (Influenza) Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)
Figure 46. North America Flu (Influenza) Vaccine Sales Market Share by Countries in 2018
Figure 47. North America Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Flu (Influenza) Vaccine Revenue Market Share by Countries in 2018
Figure 49. United States Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Flu (Influenza) Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Flu (Influenza) Vaccine Revenue Market Share by Countries in 2019
Figure 55. Germany Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Flu (Influenza) Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Flu (Influenza) Vaccine Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Flu (Influenza) Vaccine Revenue Market Share by Regions 2019
Figure 63. China Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Flu (Influenza) Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Flu (Influenza) Vaccine Sales Market Share by Countries in 2019
Figure 70. South America Flu (Influenza) Vaccine Revenue Market Share by Countries in 2019
Figure 71. Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Flu (Influenza) Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Flu (Influenza) Vaccine Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Flu (Influenza) Vaccine Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Flu (Influenza) Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Flu (Influenza) Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Flu (Influenza) Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Flu (Influenza) Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Flu (Influenza) Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Flu (Influenza) Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Flu (Influenza) Vaccine Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
インフルエンザワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Vaccine for Influenza market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…- インフルエンザウイルスベクターワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Influenza Virus Vector Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- インフルエンザNA阻害剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Influenza NA Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 遺伝子組み換えサブユニットワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Gene Engineered Subunit Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 分子インフルエンザ検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Molecular Influenza Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…